Authors: SHI J RIPLEY E GEHR TWB SICA DA DANDEKAR KA HINDERLING PH

Citation: J. Shi et al., PHARMACOKINETICS OF SEMATILIDE IN RENAL-FAILURE, Journal of clinical pharmacology, 36(2), 1996, pp. 131-143

Authors: BARBHAIYA RH DANDEKAR KA GREENE DS

Citation: Rh. Barbhaiya et al., PHARMACOKINETICS, ABSOLUTE BIOAVAILABILITY, AND DISPOSITION OF [C-14]NEFAZODONE IN HUMANS, Drug metabolism and disposition, 24(1), 1996, pp. 91-95

Authors: SHI J RIPLEY E DILEA C SICA DA GEHR TW DANDEKAR KA HINDERLING PH

Citation: J. Shi et al., EFFECT OF RENAL-FUNCTION ON PHARMACOKINETICS (PK) OF SEMATILIDE (S), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 219-219

Authors: KAUL S SHYU WC SHUKLA UA DANDEKAR KA BARBHAIYA RH

Citation: S. Kaul et al., ABSORPTION, DISPOSITION, AND METABOLISM OF [C-14] DIDANOSINE IN THE BEAGLE DOG, Drug metabolism and disposition, 21(3), 1993, pp. 447-453

Authors: KAUL S DANDEKAR KA

Citation: S. Kaul et Ka. Dandekar, PHARMACOKINETICS OF THE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS NUCLEOSIDE ANALOG STAVUDINE IN CYNOMOLGUS MONKEYS, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 1160-1162

Authors: STPETER JV BRADY ME FOOTE EF DANDEKAR KA SMALDONE L PYKKONEN JL KEANE WF HALSTENSON CE

Citation: Jv. Stpeter et al., THE DISPOSITION AND PROTEIN-BINDING OF BATANOPRIDE AND ITS METABOLITES IN SUBJECTS WITH RENAL IMPAIRMENT, European Journal of Clinical Pharmacology, 45(1), 1993, pp. 59-63